Literature DB >> 428828

Gynaecomastia associated with cimetidine.

R W Spence, L R Celestin.   

Abstract

Gynaecomastia has occurred unilaterally or bilaterally in five out of 25 male duodenal ulcer patients after more than four months treatment with cimetidine 1.6 g daily. All elected to continue treatment to 12 months and their breast enlargement regressed rapidly and disappeared after stopping treatment. During treatment all patients were found to have normal concentrations of plasma testosterone and oestradiol, and serum prolactin was normal in the two patients measured. Excision biopsy of the subareolar tissue in one patient revealed histology typical of the florid stage of gynaecomastia. Blockade of androgen-responsive receptors receptors in the target organ appears to be the most likely mechanism involved.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428828      PMCID: PMC1419438          DOI: 10.1136/gut.20.2.154

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Gynecomastia during digitalis therapy; report of eight additional cases with liver-function studies.

Authors:  E B LEWINN
Journal:  N Engl J Med       Date:  1953-02-19       Impact factor: 91.245

Review 2.  The relationship of sleep and sleep stages to neuroendocrine secretion and biological rhythms in man.

Authors:  E D Weitzman; R M Boyar; S Kapen; L Hellman
Journal:  Recent Prog Horm Res       Date:  1975

3.  Letter: Breast changes in males on cimetidine.

Authors:  W H Hall
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

4.  Gynecomastia associated with vincristine therapy.

Authors:  R H Smith; O Barrett
Journal:  Calif Med       Date:  1967-10

5.  Human prolactin: 24-hour pattern with increased release during sleep.

Authors:  J F Sassin; A G Frantz; E D Weitzman; S Kapen
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

6.  Gynecomastia: clinicopathologic study of 351 cases.

Authors:  G A Bannayan; S I Hajdu
Journal:  Am J Clin Pathol       Date:  1972-04       Impact factor: 2.493

7.  Gynaecomastia with cimetidine.

Authors:  G F Delle Fave; G Tamburrano; L De Magistris; C Natoli; M L Santoro; R Carratu; A Torsoli
Journal:  Lancet       Date:  1977-06-18       Impact factor: 79.321

8.  Galactorrhoea with cimetidine.

Authors:  M C Bateson; M C Browning; A Maconnachie
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

9.  Cimetidine and serum prolactin.

Authors:  S K Majumdar; A D Thomson; G K Shaw
Journal:  Br Med J       Date:  1978-02-18

10.  Plasma-prolactin and cimetidine.

Authors:  M Petrillo; A Prada; G B Porro; M Bevilacqua; V Raggi; G Norbiato
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

View more
  14 in total

1.  Premature thelarche: a possible adverse effect of cimetidine treatment.

Authors:  J M Bosman; N M Bax; J M Wit
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

2.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

4.  Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  BMJ       Date:  1994-02-19

Review 5.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

6.  Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.

Authors:  W Londong; V Londong; C Ruthe; P Weizert
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

7.  The effects of ranitidine on pituitary-thyroid function.

Authors:  K R Hine; J S Harrop; M R Hopton; G K Holmes; H L Matthews
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 8.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

9.  Endocrine effects of acute and chronic cimetidine administration.

Authors:  H E Carlson; A F Ippoliti; R S Swerdloff
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

Review 10.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.